Evidence map›Paper›PMID 29559739›Full record

ArticleJournal of human genetics2018

Association of a single nucleotide polymorphism in TNIP1 with type-1 autoimmune hepatitis in the Japanese population.

Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, Minoru Nakamura, Atsumasa Komori, Seigo Abiru, Shinya Nagaoka, Satoru Hashimoto, Atsushi Naganuma, Noriaki Naeshiro and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Journal of clinical medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 1 country.

Shomi OkaMolecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
Takashi HiguchiMolecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
Hiroshi FurukawaMolecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan. furukawa-tky@umin.org.ORCID http://orcid.org/0000-0002-4022-0767
Minoru NakamuraDepartment of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Atsumasa KomoriClinical Research Center, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856-8562, Japan.
Seigo AbiruNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Shinya NagaokaNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Satoru HashimotoNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Atsushi NaganumaNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Noriaki NaeshiroNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Kaname YoshizawaNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Masaaki ShimadaNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Hideo NishimuraNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Minoru TomizawaNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Masahiro KikuchiNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Fujio MakitaNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Haruhiro YamashitaNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Keisuke ArioNHO-AIH Study Group, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856‑8562, Japan.
Hiroshi YatsuhashiClinical Research Center, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856-8562, Japan.
Shigeto TohmaClinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, 18-1 Sakuradai, Minami-ku, Sagamihara, 252-0392, Japan.
Aya KawasakiMolecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
Naoyuki TsuchiyaMolecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.ORCID http://orcid.org/0000-0002-6776-5580
Kiyoshi MigitaClinical Research Center, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kubara, Omura, 856-8562, Japan.
Nagasaki Medical Center · JPUniversity of Tsukuba · JPFukushima Medical University · JPNagasaki University · JPNational Sagamihara Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several studies reported that autoimmune diseases share a number of susceptibility genes. Of these genes, a SNP rs7708392 in TNIP1 was reported to be associated with systemic lupus erythematosus (SLE). Autoimmune hepatitis (AIH), a rare chronic progressive liver disease, shares some clinical features with SLE. Therefore, we investigated whether the SNP is associated with Japanese AIH. An association study of rs7708392 was conducted in 343 Japanese AIH patients and 828 controls. We found that rs7708392 is associated with AIH (P = 0.0236, odds ratio (OR) 1.26, 95% confidence interval (CI): 1.03-1.54), under the allele model for C allele. Significant differences of clinical characteristics of the AIH patients with or without G allele of rs7708392 were not detected. Of interest, the association was stronger in AIH without HLA-DRB1*04:05 allele (P = 0.0063, Q = 0.0127, OR 1.48, 95% CI: 1.12-1.96), though the association was not detected in AIH with DRB1*04:05. The C allele of rs7708392 was associated with AIH, especially AIH without DRB1*04:05, an already established risk factor.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAgedAsian PeopleCase-Control StudiesDNA-Binding ProteinsFemaleGene FrequencyHepatitis, AutoimmuneHLA-DRB1 ChainsHumansJapanMaleMiddle AgedReal-Time Polymerase Chain ReactionDNA-Binding ProteinsHLA-DRB1 ChainsTNIP1 protein, human

Identifiers

PMID29559739
OpenAlexW2789954537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.